The global catheter-directed thrombolysis industry growth has demonstrated substantial growth and is currently valued at US$ 454.8 million in 2023. According to recent market analysis, this sector is expected to maintain a steady growth trajectory at a Compound Annual Growth Rate (CAGR) of 5.9%, reaching an estimated value of US$ 808 million by 2033.
Catheter-directed thrombolysis, a minimally invasive procedure used in the treatment of blood clots, has witnessed increased adoption owing to its efficacy and reduced risk compared to conventional treatments. This market growth is attributed to several factors, including advancements in technology, rising prevalence of vascular diseases, and growing awareness among healthcare professionals and patients regarding the benefits of this procedure.
Our Sample Report for Key Insights Catheter-directed thrombolysis industry: https://www.futuremarketinsights.com/reports/sample/rep-gb-5143
“With an anticipated CAGR of 5.9%, the catheter-directed thrombolysis market is poised for significant expansion over the next decade,” stated Future Market Insights. “This growth is fueled by continuous innovation in catheter-based technologies, expanding applications in various medical conditions, and the escalating demand for minimally invasive procedures.”
The increasing prevalence of conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE) has heightened the need for efficient and targeted treatment options, propelling the demand for catheter-directed thrombolysis procedures. Moreover, the preference for minimally invasive techniques among patients and healthcare providers due to reduced hospital stays and quicker recovery times is further bolstering market growth.
The projected value of US$ 808 million by 2033 underscores the market’s potential and the opportunities it presents for stakeholders in the healthcare industry, including medical device manufacturers, healthcare providers, and investors.
As the global catheter-directed thrombolysis market continues to expand, key players in the sector are expected to focus on technological advancements, strategic collaborations, and geographic expansion to capitalize on this growth trajectory.
Top Highlights from the FMI’s Analysis of the Catheter-directed thrombolysis industry:
- The North American catheter-directed thrombolysis industry is expected to gain 53.4% market share, with the United States enjoying the leading position in the region and globe by attaining 47% in the global market.
- Although Europe’s market share is less than half of North America’s, i.e., Europe garnered a 24.1% market share in 2022. The region still holds a prominent position in the market.
- Germany leads the European market with a market share of 4.7%.
- Japan has a value share of 3.1%, attracting businesses to delve deep into the market for revenue prospects.
- Australia’s growth rate in the market, as estimated by FMI, is expected to be 5.2% CAGR over the forecast period.
- China is expected to expand at a robust pace of 7.1% over the forecast period.
- India, another Asian country, is expected to expand at a CAGR of 5.8% from 2023 to 2033.
- The United Kingdom is expected to expand at a CAGR of 4.1% over the forecast period.
- Under the delivery mode category, direct delivery to the blood clot segment is expected to garner a market share of more than 62.8% over the forecast period.
- Based on end users, the hospital segment is expected to grab a value share of more than 47.8%.
Our Analyst Is Available To Help You With Any Inquiries You May Have: https://www.futuremarketinsights.com/ask-question/rep-gb-5143
Key Players in the News:
- In August 2022, Boston Scientific Corporation obtained Obsidio, Inc., which is a privately-owned firm that has created Gel Embolic Material (GEM) technology for the coagulum of blood vessels in the peripheral circulatory system.
- In July 2020, iVascular S.L.U introduced its sergeant peripheral support catheter for patients suffering from peripheral artery disorder or difficult anatomy during interventional and diagnostic procedures. The device delivers brilliant pushability and torque capacity due to its tapered shaft design.
Some of the key participants present in the market include:
- AngioDynamics Inc.
- Boston Scientific Corporation
- iVascular SLU
- Straub Medical AG
Customization Unleashed: Learn How to Stand Out in a Competitive Landscape: https://www.futuremarketinsights.com/customization-available/rep-gb-5143
Key Segments:
By Delivery Mode:
- Direct Delivery to Blood Clot Catheter-directed Thrombolysis
- Catheter-directed Thrombolysis by Positioning Medical Device at Clot Site
By Indication:
- Pulmonary Embolism (PE)
- Deep Vein Thrombosis (DVT)
- Strokes
- Other Indications
By End User:
- Hospitals
- Surgical Centers
- Radiology Clinics
By Region:
- North America
- Latin America
- Asia Pacific
- Middle East and Africa
- Europe
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
